PATENT CLAIM ANALYSIS

Application Number: 15756342
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-10
Patent Classification: ["514", "295000"]

Abstract:
Provided are a conjugate of memantine and arctigenin, and a pharmaceutical composition comprising the conjugate. The conjugate can treat diseases associated with Aβ or Tau protein pathways, such as Alzheimer's disease or Parkinson's disease.

Claim (Index 5):
The conjugate according to  claim 2 , which is selected from the group consisting of conjugates A01 to A55 and pharmaceutically acceptable salts, stereoisomers, polymorphs, solvates or prodrugs thereof: No. Conjugate Structure A01   A02   A03   A04   A05   A06   A07   A08   A09   A10   A11   A12   A13   A14   A15   A16   A17   A18   A19   A20   A21   A22   A23   A24   A25   A26   A27   A28   A29   A30   A31   A32   A33   A34   A35   A36   A37   A38   A39   A40   A41   A42   A43   A44   A45   A46   A47   A48   A49   A50   A51   A52   A53   A54   A55

Metadata:
- Claim Count in Document: 8.0
- Percentile: 88.0
- Lexical Diversity: 1.29032
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13063525', '16084979', '13940016', '15552556', '13442244']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7842766319389383
- 35 USC 102 Novelty (BERT): 0.4978651800033167
- Combined Prediction Score: 0.7556354867453761
- Mean Citation Score: 207.164244
- Max Citation Score: 211.74594
- Similarity Product: 137.7683360868716

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test